Stay updated on Ruxolitinib vs BAT in Chronic GvHD Clinical Trial

Sign up to get notified when there's something new on the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page’s revision label has been updated from Revision: v3.6.0 to Revision: v3.6.1. This is a minor metadata update that does not alter the study content or data presented.
    Difference
    0.0%
    Check dated 2026-06-25T01:02:26.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    28 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.5.5 label, replacing the previous Revision: v3.5.4. This indicates an update to the page's revision history rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-06-03T18:18:54.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    A new publication reference has been added to the Publications section, citing a 2026 Ther Adv Hematol article on ruxolitinib in GVHD. This addition expands the related literature linked to the REACH3 study page without modifying study details or eligibility.
    Difference
    0.0%
    Check dated 2026-05-27T17:14:25.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page's revision has been updated to v3.5.4, signaling a small maintenance or metadata update rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-05-20T14:47:05.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page now shows a revised tag 'Revision: v3.5.3', indicating an updated version of the page content. The previous revision tag 'v3.5.2' was replaced.
    Difference
    0.0%
    Check dated 2026-04-29T09:25:35.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page now displays an updated site revision marker (v3.5.2 instead of v3.5.0). This reflects a technical site/version update without changing the study information shown.
    Difference
    0.0%
    Check dated 2026-04-22T04:15:25.000Z thumbnail image

Stay in the know with updates to Ruxolitinib vs BAT in Chronic GvHD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page.